Purchase Order 36C25222P0058

The Defense Logistics Agency awarded a $123,328 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical products. Under this order, Amerisourcebergen will deliver 28 count bottles of the 10mg capsule formulation of Revlimid to a facility in Conshohocken, Pennsylvania by October 2, 2023. Revlimid is a thalidomide analogue approved for the treatment of multiple myeloma and myelodysplastic syndromes. This delivery order was issued against an existing DLA...

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 25 MG CAPSULE 21S. The $10,281.49 contract, which has a completion date of January 29, 2024, is not designated as a set-aside. Amerisourcebergen Drug Corp is a prime contractor that has received numerous federal awards from DLA to supply pharmaceuticals, medical supplies, and related distribution services...

This federal contract award is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a Delivery Order with a Firm Fixed Price type, valued at $46,660.58, and has an ultimate completion date of June 27, 2024....

The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide REVLIMID 10 MG CAPSULE 28S. This $55,719.56 contract has a completion date of March 19, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This award is not associated with any set-aside designation....

The Defense Logistics Agency Troop Support Medical awarded a $281,204.49 delivery order contract to Amerisourcebergen Drug Corp Corporate Office Division for 4557083384 REVLIMID 15 MG CAPSULE 100S. The contract has a period of performance from May 2, 2022 through May 23, 2022 and utilizes a firm fixed price pricing structure. Amerisourcebergen Drug Corp Corporate Office Division will provide the pharmaceutical product REVLIMID 15 MG CAPSULE 100S to the Defense Logistics Agency Troop Support...

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the supply of REVLIMID 10 MG CAPSULE 100S, a prescription medication, with a potential value of $211,225.76 and a performance period through March 13, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the...

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of REVLIMID 5 MG CAPSULE 100S. The firm-fixed-price contract, with a ceiling value of $89,155.06, has a period of performance through February 4, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as...

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of REVLIMID 20 MG CAPSULE 100S, a pharmaceutical product, with a ceiling value of $89,155.06. The contract has a firm fixed price pricing type and a completion date of September 20, 2024. This contract is not set aside for any specific business type. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical...

The Defense Logistics Agency awarded a firm fixed price delivery order contract worth $34,362.95 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of REVLIMID 25 MG CAPSULE 21S. This contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. This contract is related to a larger indefinite delivery contract (IDC) awarded by DLA to...

The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company AmerisourceBergen Corporation. The contract, valued at $41,399.91, is for the delivery of REVLIMID 5 MG CAPSULE 28S, a pharmaceutical product, to support military treatment programs and facilities. This contract is part of a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp,...